Cargando…

Ovostatin 2 knockdown significantly inhibits the growth, migration, and tumorigenicity of cutaneous malignant melanoma cells

BACKGROUND: We previously identified ovostatin 2 (OVOS2) as a new candidate gene for cutaneous malignant melanoma (CMM) in a Chinese population. In this study, we aimed to investigate the exact role of OVOS2 in cell proliferation, invasion, and tumorigenesis of melanoma A375 cells. METHODS: The down...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Ying-Xue, Song, Hao, Tao, Yue, Shao, Xue-Bao, Zeng, Xue-Si, Xu, Xiu-Lian, Qi, Jin-Liang, Sun, Jian-Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912766/ https://www.ncbi.nlm.nih.gov/pubmed/29684087 http://dx.doi.org/10.1371/journal.pone.0195610

Ejemplares similares

A complex of novel protease inhibitor, ovostatin homolog, with its cognate proteases in immature mice uterine luminal fluid
por: Huang, Hsien-Lu, et al.
Publicado: (2019)

microRNA-625 inhibits tumorigenicity by suppressing proliferation, migration and invasion in malignant melanoma
por: Fang, Wei, et al.
Publicado: (2017)

lncTCF7 is a negative prognostic factor, and knockdown of lncTCF7 inhibits migration, proliferation and tumorigenicity in glioma
por: Gao, Xiao, et al.
Publicado: (2017)

Prognostic significance of LKB1 promoter methylation in cutaneous malignant melanoma
por: Zhang, Weiming, et al.
Publicado: (2017)

Cutaneous malignant melanoma in Scotland.
por: MacKie, R. M., et al.
Publicado: (1982)

MALIGNANT MELANOMA – CUTANEOUS METASTASES
por: Padmavathy, L, et al.
Publicado: (2008)

Cutaneous Horn Malignant Melanoma
por: Nishida, Haruto, et al.
Publicado: (2013)

Cutavirus in Cutaneous Malignant Melanoma
por: Mollerup, Sarah, et al.
Publicado: (2017)

PSMC2 knockdown suppressed tumor progression of skin cutaneous melanoma
por: Yang, Yanwen, et al.
Publicado: (2021)

An uncommon malignant cutaneous squamomelanocytic tumor
por: WANG, HONG-YAN, et al.
Publicado: (2013)

Knockdown of CCNO decreases the tumorigenicity of gastric cancer by inducing apoptosis
por: Li, Lan, et al.
Publicado: (2018)

Exosomes released upon mitochondrial ASncmtRNA knockdown reduce tumorigenic properties of malignant breast cancer cells
por: Lobos-González, Lorena, et al.
Publicado: (2020)

On the clinical significance of cutaneous melanoma's precursors
por: Noto, Giuseppe
Publicado: (2012)

Mining Database for the Clinical Significance and Prognostic Value of ESRP1 in Cutaneous Malignant Melanoma
por: Wang, Baihe, et al.
Publicado: (2020)

High ALDH1 Expression Correlates with Better Prognosis in Tumorigenic Malignant Melanoma
por: Taylor, Laura A., et al.
Publicado: (2017)

PAQR3 suppresses the proliferation, migration and tumorigenicity of human prostate cancer cells
por: Huang, Wenqiang, et al.
Publicado: (2016)

Cutaneous malignant melanoma in Northern Ireland.
por: Pedlow, P. J., et al.
Publicado: (1997)

Primary cutaneous malignant melanoma of the breast
por: Kim, Seon Kwang, et al.
Publicado: (2012)

Long non-coding RNA FENDRR inhibits migration and invasion of cutaneous malignant melanoma cells
por: Chen, Xu-e, et al.
Publicado: (2020)

PD-L1 Promotes Self-Renewal and Tumorigenicity of Malignant Melanoma Initiating Cells
por: Zheng, Fang, et al.
Publicado: (2017)

Combination of the NRF2 Inhibitor and Autophagy Inhibitor Significantly Inhibited Tumorigenicity of Castration-Resistant Prostate Cancer
por: Zhang, Yong, et al.
Publicado: (2022)

Heat shock protein 70 downregulation inhibits proliferation, migration and tumorigenicity in hepatocellular carcinoma cells
por: Xiong, Ju, et al.
Publicado: (2017)

KCNJ14 knockdown significantly inhibited the proliferation and migration of colorectal cells
por: Li, Bin, et al.
Publicado: (2022)

Problems with registration of cutaneous malignant melanoma in England.
por: Melia, J., et al.
Publicado: (1995)

Cutaneous malignant melanoma “recurred as” or “in coexistence” with meningioma?
por: Rahmah, Nunung Nur, et al.
Publicado: (2010)

Worldwide Increasing Incidences of Cutaneous Malignant Melanoma
por: Godar, Dianne E.
Publicado: (2011)

Diffuse Cutaneous Melanosis Associated with Malignant Melanoma
por: Mangana, Joanna, et al.
Publicado: (2015)

Established and Emerging Biomarkers in Cutaneous Malignant Melanoma
por: Verykiou, Stamatina, et al.
Publicado: (2014)

Tumorigenicity of RTK/RAS in urothelium
por: Wu, Xue-Ru, et al.
Publicado: (2015)

ADCK2 Knockdown Affects the Migration of Melanoma Cells via MYL6
por: Vierthaler, Marlene, et al.
Publicado: (2022)

Knockdown of Pentraxin 3 suppresses tumorigenicity and metastasis of human cervical cancer cells
por: Ying, Tsung-Ho, et al.
Publicado: (2016)

Primary Cilium Depletion Typifies Cutaneous Melanoma In Situ and Malignant Melanoma
por: Kim, Jinah, et al.
Publicado: (2011)

HSP105 expression in cutaneous malignant melanoma: Correlation with clinicopathological characteristics
por: Chen, Ke-Jun, et al.
Publicado: (2021)

Significance of metastatic topography for the immunotherapy of cutaneous and ocular melanomas
por: Săftescu, Sorin, et al.
Publicado: (2020)

Landscape and Clinical Significance of Immune Checkpoint in Cutaneous Melanoma
por: Mao, Rui, et al.
Publicado: (2021)

ERp19 contributes to tumorigenicity in human gastric cancer by promoting cell growth, migration and invasion
por: Wu, Jing, et al.
Publicado: (2015)

Identification of significant genes with a poor prognosis in skin cutaneous malignant melanoma based on a bioinformatics analysis
por: Wang, Jin, et al.
Publicado: (2022)

Genetic determinants of cutaneous malignant melanoma in Sinclair swine.
por: Blangero, J., et al.
Publicado: (1996)

The Influence of Pregnancy on the Recurrence of Cutaneous Malignant Melanoma in Women
por: Albersen, M., et al.
Publicado: (2010)

Metastatic breast disease from cutaneous malignant melanoma()
por: Moschetta, Marco, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ajotck7lru8jr0qrgpqr6a68k9